Creation of secondary arteriovenous fistulas: maximizing fistulas in prevalent hemodialysis patients

National Kidney Foundation Dialysis Outcomes Quality Initiative (NKF-DOQI) guideline 29 suggests that a patient should be evaluated for a secondary arteriovenous fistula (AVF) following each episode of dialysis access failure. Regretfully, it does not appear that this approach is used, even though r...

Full description

Saved in:
Bibliographic Details
Published in:Seminars in dialysis 2005-09, Vol.18 (5), p.420-424
Main Authors: Asif, Arif, Unger, Stephen W, Briones, Patricia, Merrill, Donna, Cherla, Gautam, Lenz, Oliver, Roth, David, Pennell, Phillip
Format: Article
Language:English
Subjects:
Adult
Aged
Arteries - pathology
Arteries - physiopathology
Arteriovenous Fistula - etiology
Arteriovenous Fistula - physiopathology
Arteriovenous Shunt, Surgical - adverse effects
Female
Forearm - blood supply
Humans
Kidney Failure, Chronic - physiopathology
Kidney Failure, Chronic - therapy
Male
Middle Aged
Renal Dialysis - adverse effects
Vascular Patency
Veins - pathology
Veins - physiopathology
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:National Kidney Foundation Dialysis Outcomes Quality Initiative (NKF-DOQI) guideline 29 suggests that a patient should be evaluated for a secondary arteriovenous fistula (AVF) following each episode of dialysis access failure. Regretfully, it does not appear that this approach is used, even though recent data have emphasized that veins suitable for the creation of a secondary AVF can be identified in dialysis patients who are receiving dialysis via a synthetic arteriovenous graft (AVG) or other type of potentially dysfunctional vascular access. In this study nine patients (five with an AVG and four with an AVF) with vascular access dysfunction undergoing percutaneous interventions were evaluated for secondary AVF creation. All were found to have suitable vascular anatomy and had the AVF created. The secondary fistula was successful in all nine patients with a mean follow-up of 4.8 +/- 1.4 months in post-AVG cases and 5.6 +/- 1.7 months in the post-AVF patients. In addition, it was possible to continue uninterrupted dialysis without the use of a tunneled dialysis catheter in three of the patients with AVGs. This experience demonstrates the validity and success of this approach to the management of dialysis access dysfunction. In the ongoing effort to optimize vascular health status, we suggest that during percutaneous interventions, patients should routinely have identification of vessels suitable for creation of a secondary AVF.
ISSN:0894-0959
1525-139X
DOI:10.1111/j.1525-139X.2005.00080.x